VYNE Therapeutics Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
VYNE Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • VYNE Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.29 USD/shares, a 85.6% increase year-over-year.
  • VYNE Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 3.4 USD/shares.
  • VYNE Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -2.78 USD/shares, a 61.8% increase from 2022.
  • VYNE Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -7.28 USD/shares, a 71.6% increase from 2021.
  • VYNE Therapeutics Inc. annual Earnings Per Share, Basic for 2021 was -25.6 USD/shares, a 425% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3 +$4.50 +61.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 -$7 +$18.40 +71.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 -$26 -$34 -425% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $7.88 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.